跳至主要内容
临床试验/2024-517679-18-00
2024-517679-18-00招募中4 期

Effect of proton pump inhibitors on the structural integrity of endoscopic sleeve gastroplasty: a single-centre open-label, randomized, controlled pilot clinical trial

Fondazione Policlinico Universitario Agostino Gemelli IRCCS1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年12月2日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
40
试验地点
1
主要终点
the assess the effect of PPIs on the proportion of patients with “Intact ESG”, “open ESG” and “partially intact ESG” at 6 months of follow-up

研究概览

简要总结

To evaluate the effect of PPI’s on the structural integrity of the ESG

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65+ years(65+ Years, 18-64 Years)
接受健康志愿者

入选标准

  • Age 20 to 65 years
  • BMI between 30 to 45 kg/m2
  • Willingness to participate in the study and ability to comply and understand the study protocol

排除标准

  • Active gastric gastro-duodenal during the last 6 months
  • Continuous glucocorticoid or anti-inflammatory treatment
  • Uncontrolled thyroid disease
  • Pregnancy, breastfeeding
  • Psychiatric or cooperative problems or low compliance that is a contraindication from participating in the study
  • Hiatal hernia ≥ 5 cm
  • Known allergy or hypersensitivity to the active substance or any of the other excipients
  • Liver cirrhosis of any Child-Phugh stage or MELD> 15
  • Chronic Severe Renal Insufficiency (eGFR < 30 ml/min/1.73 m2 based on CKD-EPI equation)
  • Currently participating in other study, or previously participated in an experimental drugs trial within 30 days before or 5 half-life of the drug administered
  • Any health issue that might put the patient at risk if the treatment is performed, judged by the investigator.
  • Helicobacter pylori infection
  • Organic or motility disorder of the stomach and / or esophagus
  • Anticoagulant treatment
  • Previous bariatric surgery or any other type of surgery of the esophagus, stomach and duodenum
  • Ongoing or active malignancy during the last 5 years
  • Myocardial infarction during the past 6 months or/and heart failure class III or IV according to the New York Heart association’s classification
  • Drug or alcohol abuse
  • Bulimic or binge eating pattern

结局指标

主要结局

the assess the effect of PPIs on the proportion of patients with “Intact ESG”, “open ESG” and “partially intact ESG” at 6 months of follow-up

the assess the effect of PPIs on the proportion of patients with “Intact ESG”, “open ESG” and “partially intact ESG” at 6 months of follow-up

次要结局

  • to assess the effect of PPI on the proportion of patients with “intact ESG”, “partially intact ESG” and “open ESG”, separately, at 12 months of follow-up.

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Ivo Boskoski

Scientific

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

研究点 (1)

Loading locations...

相似试验